Organometallic multi-modal contrast media

Organometallic multi-modal contrast media is a research-stage diagnostic imaging agent being developed by Laboratorios Juste and its chemical division, Justesa Imagen. Covered under patent WO2022129508, these organometallic small molecules are designed to function as multi-modal contrast media, providing contrast enhancement across multiple diagnostic imaging modalities (such as X-ray, CT, or MRI). The specific chemical structures and detailed mechanisms of action are not publicly disclosed, and the program is currently in the research or patent stage.

Other names

WO2022129508WO-2022129508WO 2022129508compuestos organometálicos y su uso como medio de contraste multimodal para el diagnóstico por imágenesorganometallic compounds and their use as multi-modal contrast media for image diagnostics